TRDA Entrada Therapeutics, Inc.

NASDAQ
$5.68

Entrada Therapeutics, Inc. (TRDA) SEC Filings

Everything TRDA has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

66 filings
Date Form Filing
SCHEDULE 13D/A View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
144/A View filing
10-Q View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
10-Q View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
10-K View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
10-Q View filing
4 View filing
4 View filing
4 View filing
4 View filing
10-Q View filing
10-Q View filing
10-K View filing
10-Q View filing
10-Q View filing
10-Q View filing
10-K View filing
10-Q View filing
10-Q/A View filing
10-K/A View filing
10-Q View filing
10-Q View filing
10-K View filing
10-Q View filing
10-Q View filing
10-Q View filing
10-K View filing
10-Q View filing

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.